A revolutionary handheld and battery-powered DNA diagnostic device invented at the University of Otago is poised to become a commonly used field tool for rapidly detecting suspected viruses or bacteria in samples while also determining the level of infection.
The breakthrough device, dubbed Freedom4, will be unveiled today at the Queenstown Molecular Biology main meeting. It takes advantage of a technology called quantitative PCR to identify target DNA sequences in real-time, without the need for further processing.
As an example, using Freedom4, the presence and extent of norovirus infection in a sample could be confirmed within less than an hour, while the person using the unit was still at the outbreak site.
Dr Jo-Ann Stanton, who led the programme to develop the device, says that as well as enabling ‘anytime, anywhere’ clinical diagnosis of viral infectious diseases in humans and animals, it also has many other potential uses, such as border security, forensics or environmental monitoring.
Developed by Dr Stanton’s multidisciplinary team at Otago’s Department of Anatomy, the sturdy unit weighs the same as a typical laptop and fits on the palm of your hand. Freedom4 boasts a six-hour battery life and can be tethered to a laptop, or connect wirelessly to smart phones or tablets running custom software that analyses and interprets the test results.
“This mobility could provide a great boon for farmers. For instance, vets could drive around a farm analysing samples from various locations, make their diagnoses and treat infected animals-all in one trip,” she says.
The Latest on: DNA diagnostics
via Google News
The Latest on: DNA diagnostics
- Quest Diagnostics Launches Monkeypox Virus Testingon August 1, 2022 at 6:55 am
With the new automated test, Quest expects to be able to perform approximately 30,000 monkeypox virus tests a week by the end of July. Depending on demand, Quest can expand capacity for monkeypox ...
- Human Recombinant DNA Global Markets Research Report 2022 - ResearchAndMarkets.comon August 1, 2022 at 3:51 am
This report highlights the current and future market potential for human recombinant DNA and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, ...
- Global DNA Extraction Kit Market Analysis/Research Report 2022on July 29, 2022 at 3:53 am
The "DNA Extraction Kit Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The center of the genomic revolution is DNA and the IT infrastructure ...
- Programming pH: New technique could accelerate DNA synthesison July 27, 2022 at 11:00 am
H—the concentration of protons in a watery solution—indicates how acidic the solution is. It regulates a broad range of natural and engineered chemical processes, including the synthesis of designed ...
- Co-Diagnostics, Inc. to Participate in Yale University SalivaDirect™ Conference Held July 28-29 in Chicagoon July 27, 2022 at 8:30 am
Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it ...
- SomaLogic acquires DNA nanotechnology company Palamedrixon July 27, 2022 at 3:26 am
SomaLogic, an AI data-driven proteomics technology, today announced it has entered into an agreement to acquire Palamedrix, Inc.
- Meridian Diagnostics Helps Your Practice Make Better Healthcare Decisionson July 26, 2022 at 3:31 pm
When connecting with anyone from the Meridian Diagnostics team, the first thing you’ll notice is that the company strives to help medical professionals make better healthcare decisions through ...
- 'Junk' DNA May Stall Replication, Increasing Cancer Riskon July 21, 2022 at 2:10 am
Huge sections of the human genome are made up of highly repetitive sequences, areas where bases like ATATAT repeat in long strings. | Cell And Molecular Biology ...
- Global Molecular Diagnostics Market to Surpass US$ 35,500.8 Million by 2030 - Coherent Market Insightson July 20, 2022 at 10:30 am
According to Coherent Market Insights, the global molecular diagnostics market is estimated to be valued at US$ 14,772.2 million in 2022 and is expected to exhibit a CAGR of 11.6 % during the forecast ...
- Prenatal diagnostics: Expectant parents should be able to make an informed decisionon July 20, 2022 at 8:05 am
Prenatal diagnostic examinations provide information about possible anomalies, hereditary diseases and malformations of the fetus long before birth. However, the procedures are not without risks. The ...
via Bing News